Lv3
370 积分 2025-01-20 加入
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial
21天前
已完结
Top advances of the year: Bladder cancer
22天前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
22天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
26天前
已完结
Advancing CAR T-Cell Therapy
27天前
已完结
Renal cell carcinoma
1个月前
已完结
Recent Developments in the Management of Renal Cell Cancer
1个月前
已完结
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
1个月前
已完结
T-cell Engagers in Prostate Cancer
2个月前
已完结
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer
2个月前
已完结
皖公网安备34019202002308
